Fu Xi Long, Schiffman Mark, Ke Yang, Hughes James P, Galloway Denise A, He Zhonghu, Hulbert Ayaka, Winer Rachel L, Koutsky Laura A, Kiviat Nancy B
Department of Pathology, School of Medicine, University of Washington, Seattle, WA.
Department of Epidemiology, University of Washington, Seattle, WA.
Int J Cancer. 2017 Apr 15;140(8):1747-1756. doi: 10.1002/ijc.30594. Epub 2017 Jan 24.
Studies of the clinical relevance of human papillomavirus (HPV) DNA load have focused mainly on HPV16 and HPV18. Data on other oncogenic types are rare. Study subjects were women enrolled in the atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL) triage study who had ≥1 of 11 non-HPV16/18 oncogenic types detected during a 2-year follow-up at 6-month intervals. Viral load measurements were performed on the first type-specific HPV-positive specimens. The association of cervical intraepithelial neoplasia grades 2-3 (CIN2/3) with type-specific HPV DNA load was assessed with discrete-time Cox regression. Overall, the increase in the cumulative risk of CIN2/3 per 1 unit increase in log -transformed viral load was statistically significant for four types within species 9 including HPV31 (adjusted hazard ratio [HR ] = 1.32: 95% confidence interval [CI], 1.14-1.52), HPV35 (HR = 1.47; 95% CI, 1.23-1.76), HPV52 (HR = 1.14; 95% CI, 1.01-1.30) and HPV58 (HR = 1.49; 95% CI, 1.23-1.82). The association was marginally significant for HPV33 (species 9) and HPV45 (species 7) and was not appreciable for other types. The per 1 log -unit increase in viral load of a group of species 9 non-HPV16 oncogenic types was statistically significantly associated with risk of CIN2/3 for women with a cytologic diagnosis of within normal limits, ASC-US, or LSIL at the first HPV-positive visit but not for those with high-grade SIL. Findings suggest that the viral load-associated risk of CIN2/3 is type-dependent, and mainly restricted to the species of HPV types related to HPV16, which shares this association.
人乳头瘤病毒(HPV)DNA载量的临床相关性研究主要集中在HPV16和HPV18上。关于其他致癌类型的数据很少。研究对象为参加意义不明确的非典型鳞状细胞(ASC-US)和低级别鳞状上皮内病变(LSIL)分流研究的女性,她们在为期2年、每6个月一次的随访期间检测出11种非HPV16/18致癌类型中的至少一种。对首次特定类型HPV阳性标本进行病毒载量测量。采用离散时间Cox回归评估宫颈上皮内瘤变2-3级(CIN2/3)与特定类型HPV DNA载量之间的关联。总体而言,在9型中的四种类型中,对数转换病毒载量每增加1个单位,CIN2/3累积风险的增加具有统计学意义,包括HPV31(校正风险比[HR]=1.32:95%置信区间[CI],1.14-1.52)、HPV35(HR=1.47;95%CI,1.23-1.76)、HPV52(HR=1.14;95%CI,1.01-1.30)和HPV58(HR=1.49;95%CI,1.23-1.82)。HPV33(9型)和HPV45(7型)的关联接近显著,而其他类型则不明显。一组9型非HPV16致癌类型的病毒载量每增加log-1单位,对于首次HPV阳性就诊时细胞学诊断为正常范围、ASC-US或LSIL的女性,与CIN2/3风险具有统计学显著关联,但对于高级别SIL女性则不然。研究结果表明,CIN2/3的病毒载量相关风险具有类型依赖性,并且主要限于与HPV16相关的HPV类型,HPV16也有这种关联。